ifosfamide - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
HOLOXAN ifosfamide 1g powder for injection vial (OF) AUST R: 43608 Active ingredients: ifosfamide Dosage form: Injection, powder for Sponsor: Baxter Healthcare Pty Ltd Phone: 1300 302 409	From 18 Jun 2026 to 14 Sep 2026	Shortage status: Current Availability: Limited Availability Reason: Unexpected increase in consumer demand Management action: The sponsor is closely controlling the supply. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.
HOLOXAN ifosfamide 2g powder for injection vial (OF) AUST R: 43609 Active ingredients: ifosfamide Dosage form: Injection, powder for Sponsor: Baxter Healthcare Pty Ltd Phone: 1300302409	From 16 Mar 2026 to 17 Jul 2026	Shortage status: Current Availability: Unavailable Reason: Manufacturing Management action: Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.

Product details

Supply Impact Dates

Further Details

HOLOXAN ifosfamide 1g powder for injection vial (OF)
AUST R: 43608
Active ingredients:
ifosfamide

Dosage form:
Injection, powder for

Sponsor:
Baxter Healthcare Pty Ltd

Phone:
1300 302 409

From
18 Jun 2026
to
14 Sep 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in consumer demand

Management action:
The sponsor is closely controlling the supply. Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.

HOLOXAN ifosfamide 2g powder for injection vial (OF)
AUST R: 43609
Active ingredients:
ifosfamide

Dosage form:
Injection, powder for

Sponsor:
Baxter Healthcare Pty Ltd

Phone:
1300302409

From
16 Mar 2026
to
17 Jul 2026

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Overseas-registered products have been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals. Alternative unapproved products may be available under the Special Access Scheme. For further information about the SAS scheme please see https://www.tga.gov.au/form/special-access-scheme. A TGA web statement is available at: https://www.tga.gov.au/safety/shortages-and-supply-disruptions/medicine-shortages/major-or-ongoing-medicine-shortages/about-cyclophosphamide-and-ifosfamide-injection-shortages.